Mancosu, Pietro
 Distribuzione geografica
Continente #
NA - Nord America 6.866
AS - Asia 3.916
EU - Europa 1.323
SA - Sud America 761
AF - Africa 190
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 6
Totale 13.080
Nazione #
US - Stati Uniti d'America 6.736
SG - Singapore 2.381
BR - Brasile 623
CN - Cina 616
VN - Vietnam 467
DE - Germania 347
FI - Finlandia 216
IE - Irlanda 196
HK - Hong Kong 117
NG - Nigeria 116
FR - Francia 115
IT - Italia 104
NL - Olanda 76
GB - Regno Unito 72
CA - Canada 62
IN - India 60
AR - Argentina 45
RU - Federazione Russa 39
SE - Svezia 38
TR - Turchia 36
BD - Bangladesh 34
IQ - Iraq 32
EC - Ecuador 31
MX - Messico 30
CL - Cile 21
ID - Indonesia 21
PK - Pakistan 20
IL - Israele 19
AT - Austria 18
ZA - Sudafrica 18
PL - Polonia 17
SA - Arabia Saudita 17
ES - Italia 16
AU - Australia 15
BE - Belgio 15
MA - Marocco 13
VE - Venezuela 12
UA - Ucraina 11
UZ - Uzbekistan 11
CO - Colombia 10
CZ - Repubblica Ceca 10
JP - Giappone 10
KZ - Kazakistan 10
MY - Malesia 10
DZ - Algeria 9
EG - Egitto 9
OM - Oman 9
JO - Giordania 8
NP - Nepal 8
CR - Costa Rica 7
HN - Honduras 7
JM - Giamaica 7
PY - Paraguay 7
KE - Kenya 6
PE - Perù 6
TN - Tunisia 6
BH - Bahrain 5
DO - Repubblica Dominicana 5
LT - Lituania 5
PH - Filippine 5
RO - Romania 5
UY - Uruguay 5
AZ - Azerbaigian 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
DK - Danimarca 3
KR - Corea 3
PS - Palestinian Territory 3
UG - Uganda 3
CH - Svizzera 2
EU - Europa 2
GD - Grenada 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PA - Panama 2
SN - Senegal 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CG - Congo 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LK - Sri Lanka 1
Totale 13.066
Città #
Dallas 1.097
Singapore 1.074
Wilmington 942
Chandler 742
San Mateo 361
The Dalles 328
Ashburn 295
Ann Arbor 253
Shanghai 253
Falkenstein 226
Helsinki 215
San Jose 201
Dublin 193
Leawood 173
Lawrence 154
Princeton 154
Boardman 141
Ho Chi Minh City 135
Beijing 129
Hanoi 124
Benin City 116
Fairfield 114
New York 105
Hong Kong 98
Woodbridge 87
Paris 79
Amsterdam 64
São Paulo 58
Santa Clara 57
Los Angeles 44
Seattle 37
London 31
Milan 28
San Diego 26
Toronto 25
Rio de Janeiro 23
Buffalo 21
Da Nang 21
Norwalk 21
Haiphong 20
Council Bluffs 18
Belo Horizonte 17
Orem 17
Brussels 15
Kocaeli 15
Baghdad 14
Guayaquil 13
Mexico City 13
Chennai 12
Columbus 12
Curitiba 12
Hillsboro 12
Vienna 12
Biên Hòa 11
Frankfurt am Main 11
Johannesburg 11
Montreal 11
Boos 10
Campinas 10
Can Tho 10
Tashkent 10
Brasília 9
Munich 9
Ninh Bình 9
Nuremberg 9
Phoenix 9
Porto Alegre 9
Quito 9
Salvador 9
Tokyo 9
Brooklyn 8
Des Moines 8
Dhaka 8
Fortaleza 8
Guarulhos 8
Lahore 8
Redwood City 8
Santiago 8
Thái Bình 8
Warsaw 8
Amman 7
Chicago 7
Denver 7
Hải Dương 7
Moscow 7
Redmond 7
San Francisco 7
Asunción 6
Bathurst 6
Genoa 6
Goiânia 6
Houston 6
Monmouth Junction 6
Mumbai 6
Riyadh 6
San José 6
Santo André 6
Ankara 5
Astana 5
Berlin 5
Totale 8.816
Nome #
11C-Choline-Pet Guided Stereotactic Body Radiation Therapy for Lymph Node Metastases in Oligometastatic Prostate Cancer. 754
11C Choline PET Guided Salvage Radiotherapy with Volumetric Modulation Arc Therapy and Hypofractionation for Recurrent Prostate Cancer after HIFU Failure: Preliminary Results of Tolerability and Acute Toxicity 679
"Early Clinical Assessment Of Feasibility And Safety In Flattering Filter Free (FFF) Based Stereotactic Body Radiotherapy (SBRT) Treatments" 133
Assessment of prognostic factors in patients with metastatic epidural spinal cord compression (MESCC) from solid tumor after surgery plus radiotherapy: a single institution experience 129
SALVAGE RADIOTHERAPY WITH VOLUMETRIC MODULATION ARC THERAPY AND HYPOFRACTIONATION FOR RECURRENT PROSTATE CANCER AFTER HIFU FAILURE 103
Accuracy evaluation of the optical surface monitoring system on EDGE linear accelerator in a phantom study. 101
Cranio-spinal irradiation with volumetric modulated arc therapy: A multi-institutional treatment experience 100
Adjuvant radiotherapy in endometrial cancer: Volumetric Modulated Intensity Arc Therapy vs 3DRT 99
Computed tomography based radiomic signature as predictive of survival and local control after stereotactic body radiation therapy in pancreatic carcinoma 97
Applying failure mode effects and criticality analysis in radiotherapy: Lessons learned and perspectives of enhancement 96
Stereotactic Ablative Radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach 96
Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients 88
Phase II trial of stereotactic body radiation therapy for abdomino-pelvic lymph node oligometastases 88
Early Surgical Experience with Minimally Invasive Percutaneous Approach for Patients with Metastatic Epidural Spinal Cord Compression (MESCC) to Poor Prognoses 87
Deep learning-based optimization of field geometry for total marrow irradiation delivered with volumetric modulated arc therapy 85
Oligometastatic Prostate Cancer Treated with Stereotactic Body Radiation Therapy: The Role of Three-Dimensional Tumour Volume in Patient Survival 85
Investigation on the role of integrated PET/MRI for target volume definition and radiotherapy planning in patients with high grade glioma 84
Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer 84
SBRT in unresectable advanced pancreatic cancer: preliminary results of a mono-institutional experience. 84
Organs at risk in lung SBRT 83
Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments. 82
CRITICAL APPRAISAL OF VOLUMETRIC MODULATED ARC THERAPY IN STEREOTACTIC BODY RADIATION THERAPY FOR METASTASES TO ABDOMINAL LYMPH NODES 82
STEREOTACTIC BODY RADIATION THERAPY AS LOCAL TREATMENT FOR OLIGOMETASTASES FROM PROSTATE CANCER: EFFICACY AND IMPACT ON SYSTEMIC TREATMENT 81
Comparison of low dose total marrow/total lymphoid irradiation (TMI/TLI) and TBI in haploidentical transplant platform: a retrospective analysis 80
VOLUMETRIC MODULATION ARC RADIOTHERAPY COMPARED WITH STATIC GANTRY INTENSITY-MODULATED RADIOTHERAPY FOR MALIGNANT PLEURAL MESOTHELIOMA TUMOR: A FEASIBILITY STUDY 80
Plan robustness in field junction region from arcs with different patient orientation in total marrow irradiation with VMAT. 79
Adjuvant chemotherapy and hypofractionated VMAT treatment with SIB for early stage breast cancer 79
Applying Lean-Six-Sigma Methodology in radiotherapy: Lessons learned by the breast daily repositioning case 79
Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification? 79
Stereotactic Body Radiation Therapy (SBRT) for adrenal metastases A Feasibility Study of Advanced Techniques with Modulated Photons and Protons 78
Stereotactic body radiation therapy for abdominal targets using volumetric intensity modulated arc therapy with RapidArc: Feasibility and clinical preliminary results 77
Dosimetric evaluation of different radiotherapy modalities and calculations for soft tissue sarcoma 77
Moderate hypofractionation and simultaneous integrated boost with volumetric modulated arc therapy (RapidArc) for prostate cancer Report of feasibility and acute toxicity 76
Minimally Invasive Stereotactical Radio-ablation of Adrenal Metastases as an Alternative to Surgery. 76
SBRT Dose Escalation Phase II Study for Liver Metastases Using Volumetric Modulated Arc Therapy (VMAT-RapidArc) 76
Automatic planning of the lower extremities for total marrow irradiation using volumetric modulated arc therapy 75
The challenge of inoperable hepatocellular carcinoma (HCC): results of a single-institutional experience on stereotactic body radiation therapy (SBRT) 75
Is Stereotactic Body Radiation Therapy an Attractive Option for Unresectable Liver Metastases? A Preliminary Report From a Phase 2 Trial 75
Semiautomatic method to identify the best phase for gated RT in lung region by 4D-PET/CT acquisitions 74
High-quality Linac-based Stereotactic Body Radiation Therapy with Flattening Filter Free Beams and Volumetric Modulated Arc Therapy for Low–Intermediate Risk Prostate Cancer. A Mono-institutional Experience with 90 Patients 74
Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments 74
Interplay effects between dose distribution quality and positioning accuracy in total marrow irradiation with volumetric modulated arc therapy 74
Clinical results of stereotactic body radiotherapy (SBRT) in the treatment of isolated local recurrence of pancreatic cancer after R0 surgery: A retrospective study. 74
RapidPlan head and neck model: the objectives and possible clinical benefit. 73
FIVE FRACTIONS LINAC BASED SBRT FOR LOW - INTERMEDIATE RISK PROSTATE CANCER: PRELIMINARY REPORT OF A PHASE II STUDY WITH FLATTENING FILTER FREE DELIVERY AND SPACE OAR 73
CLINICAL OUTCOME OF HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY FOR ABDOMINAL LYMPH NODE METASTASES 72
Feasibility and early clinical assessment of flattening filter free (FFF) based stereotactic body radiotherapy (SBRT) treatments 72
Radiomics signature as predictors of survival and local control after pancreatic carcinoma SBRT 72
Outcome and toxicity profiles in the treatment of locally advanced lung cancer with volumetric modulated arc therapy. 72
MLC parameters evaluation in a RT-dedicated MC environment (PRIMO) from static fields to VMAT plans 72
Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment 71
Volumetric Modulated Arc Therapy After Lung Sparing Surgery for Malignant Pleural Mesothelioma: A Single Institution Experience 71
Role of Stereotactic Body Radiation Therapy for the Management of Oligometastatic Renal Cell Carcinoma 71
Moderate hypofractionation and SIB with volumetric modulated arc therapy (RapidArc) for anal cancer 71
MULTIMODAL APPROACH TO THE MANAGEMENT OF METASTATIC EPIDURAL SPINAL CORD COMPRESSION (MESCC) DUE TO SOLID TUMORS 70
Role of stereotactic body radiation therapy in the treatment of liver metastases: clinical results and prognostic factors 70
Linac-based stereotactic body radiation therapy vs moderate hypofractionated radiotherapy in prostate cancer: propensity-score based comparison of outcome and toxicity 70
PRECLINICAL ASSESSMENT OF VOLUMETRIC MODULATED ARC THERAPY FOR TOTAL MARROW IRRADIATION 70
Deep learning and atlas-based models to streamline the segmentation workflow of total marrow and lymphoid irradiation 69
Evaluation of a radiotherapy-dedicated Monte Carlo environment in clinical VMAT plans. 69
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up 69
Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma Feasibility and tolerability in elderly and chemotherapy-ineligible patients 69
Stereotactic Body Radiation Therapy for Intermediate-risk Prostate Cancer With VMAT and Real-time Electromagnetic Tracking: A Phase II Study 69
Development of an immobilization device for Total Marrow Irradiation 68
Volumetric-modulated arc stereotactic body radiotherapy for prostate cancer: dosimetric impact of an increased near-maximum target dose and of a rectal spacer. 68
Radiation therapy of anal canal cancer: from conformal therapy to volumetric modulated arc therapy. 68
Hypofractionated Stereotactic Radiotherapy and Radiosurgery for the Treatment of Patients with Radioresistant Brain Metastases 68
SABR in inoperable liver oligometastatic patients and radioresistant primary tumors 68
MLC parameters from static fields to VMAT plans: an evaluation in a RT-dedicated MC environment (PRIMO) 67
Large volume unresectable locally advanced non-small cell lung cancer: acute toxicity and initial outcome results with rapid arc 67
Total Marrow Irradiation: A Clinical Evaluation of a Volumetric Modulated Arc Therapy Technique 67
Impact of C-11-methionine positron emission tomography/computed tomography on radiation therapy planning and prognosis in patients with primary brain tumors 67
Linac based SBRT for prostate cancer in 5 fractions with VMAT and flattening filter free beams: Preliminary report of a phase II study 66
Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy. 66
Cone beam CT pre- and post-daily treatment for assessing geometrical and dosimetric intrafraction variability during radiotherapy of prostate cancer 66
Study of the radioluminesence spectra of doped silica optical fibre dosimeters for stem effect removal 66
Does deep inspiration breath hold reduce plan complexity? Multicentric experience of left breast cancer radiotherapy with volumetric modulated arc therapy 66
Re-irradiation of metastatic spinal cord compression: A feasibility study by volumetric-modulated arc radiotherapy for in-field recurrence creating a dosimetric hole on the central canal 66
What is the role of [11C]choline PET/CT in decision making strategy before post-operative salvage radiation therapy in prostate cancer patients? 66
Are pitch and roll compensations required in all pathologies? A data analysis of 2945 fractions. 65
Total monitor units influence on plan quality parameters in volumetric modulated arc therapy for breast case 65
Influence of "radioresistant" histologies on SBRT outcome for lung metastases 65
Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy. 64
Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy. 64
Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy 64
Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation. 64
Phase III randomized trial comparing two modalities of RS for brain metastases: Gammaknife vs Linac 64
Unresectable Locally Advanced Non-small Cell Lung Cancer: Early Clinical Experience for Large Volume Targets using Volumetric Modulated Arc Therapy 64
Role of SBRT with VMAT technique and FFF beams for lymph-node metastases in oligometastatic patients from genitourinary malignancies 64
GAMMAKNIFE VERSUS LINAC BASED (EDGE) RADIOSURGERY (SRS) FOR PATIENTS WITH LIMITED BRAIN METASTASES (BMS) FROM DIFFERENT SOLID TUMOR: A PHASE III RANDOMIZED TRIAL 64
Reply to the Letter to the editor on Cranio-spinal irradiation with volumetric modulated arc therapy by G. Saini et al. 63
Pretreatment quality assurance of flattening filter free beams on 224 patients for intensity modulated plans: A multicentric study 63
Hypofractionation with VMAT versus 3DCRT in Post-operative Patients with Prostate Cancer. 63
Phase I-II Study of Hypofractionated Simultaneous Integrated Boost (SIB) for Adjuvant Radiation Therapy in Early Breast Cancer Patients: A Report of Feasibility and Acute Toxicity Results in the First 50 Treatments 63
Lean-six-sigma methodology for improving quality in RT: the breast daily repositioning case 63
Low dose total marrow/total lymphoid irradiation (TMI/TLI) instead of TBI induce full donor chimerism before T-replete haploidentical transplantation (TR-H). 63
STEREOTACTIC BODY RADIOTHERAPY (SBRT) USING VOLUMETRIC MODULATED ARC THERAPY (VMAT) WITH FLATTENING FILTER FREE (FFF) MODALITY FOR MEDICALLY INOPERABLE EARLY STAGE NON SMALL-CELL LUNG CANCER (NSCLC): A PROSPECTIVE SINGLE INSTITUTIONAL EXPERIENCE 63
Volumetric modulated arc therapy with flattening filter free beams for isolated abdominal/pelvic lymph nodes: Report of dosimetric and early clinical results in oligometastatic patients 63
Small field characterization of a Nanochamber prototype under flattening filter free photon beams 62
SBRT In Oligometastatic Ovarian Cancer: A Promising Therapeutic Approach 62
Totale 8.751
Categoria #
all - tutte 84.452
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.452


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021168 0 0 0 0 0 0 0 0 0 0 0 168
2021/2022715 42 8 10 200 4 3 30 122 69 56 151 20
2022/20232.230 338 44 179 261 191 192 3 194 435 188 180 25
2023/20241.081 73 137 252 45 41 92 29 39 54 25 118 176
2024/20251.611 26 40 31 20 34 189 107 205 224 394 186 155
2025/20265.839 658 454 987 533 142 185 1.252 529 470 309 168 152
Totale 13.180